Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente CANCER RESEARCH

Tipo Año Título Fuente
Resumen congreso2023A tumor-promoting senescent secretome triggered by platinum chemotherapy exploits a targetable TGFβR1/Akt-mTOR axis in lung cancerCANCER RESEARCH
Resumen congreso2023Primary results of SOLTI-1503 PROMETEO phase 2 trial of Combination of Talimogene Laherparepvec (T-VEC) with Atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapyCANCER RESEARCH
Resumen congreso2023Unicentric experience with icdk4/6 in metastatic breast cancerCANCER RESEARCH
Artículo2022Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target InhibitionCANCER RESEARCH
Artículo2021MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid LeukemiaCANCER RESEARCH
Resumen congreso2020SOLTI-1503 PROMETEO: Combination of talimogene laherparepvec (T-VEC) with atezolizumab in patients with residual breast cancer after standard neoadjuvant multi-agent chemotherapyCANCER RESEARCH
Artículo2020STAT3-Mediated Astrocyte Reactivity Associated with Brain Metastasis Contributes to Neurovascular DysfunctionCANCER RESEARCH
Resumen congreso2019Biomarker analysis by baseline circulating tumor DNA alterations in the MONALEESA-3 studyCANCER RESEARCH
Resumen congreso2019Ribociclib plus letrozole in patients with hormone receptor-positive (HR plus ), human epidermal growth factor receptor 2-negative (HER2) advanced breast cancer (aBC) with no prior endocrine therapy (ET) for ABC: CompLEEment-1 trial, preliminary results from Spanish populationCANCER RESEARCH
Resumen congreso2018A multicenter phase II trial to evaluate the efficacy and safety of pembrolizumab and gemcitabine in patients with HER2-negative advanced breast cancer: GEICAM/2015-04 PANGEA-BreastCANCER RESEARCH
Resumen congreso2018Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated results from the BERENICE studyCANCER RESEARCH
Ponencia2016Characterization of circulating monocyte infiltration in brain metastasisCANCER RESEARCH
Resumen congreso2016DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypesCANCER RESEARCH
Resumen congreso2016Epigenetic profiling uncovers the suppressive role of caveolae in Ewing sarcomaCANCER RESEARCH
Resumen congreso2016Epigenomic profiling identifies NCRNAs as novel tumor suppressors in developmental tumorsCANCER RESEARCH
Ponencia2016Polymerase kappa determines the sensitivity of MTH1 inhibitors to cisplatin-resistant cellCANCER RESEARCH
Letter2015Bufalin Is a Steroid Receptor Coactivator Inhibitor-LetterCANCER RESEARCH
Resumen congreso2015Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancerCANCER RESEARCH
Artículo2015Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2(-/-)IL2R gamma(null) Immunodeficient MiceCANCER RESEARCH
Resumen congreso2015Prospective study of the impact of the Prosigna (TM) assay on adjuvant clinical decision-making in women with estrogen receptor-positive, HER2-negative, node-negative breast cancer: A GEICAM studyCANCER RESEARCH
Artículo2014Activated ERBB2/HER2 Licenses Sensitivity to Apoptosis upon Endoplasmic Reticulum Stress through a PERK-Dependent PathwayCANCER RESEARCH
Ponencia2011The multitasking of Sox2: Maintaining the stemness and inducing the malignant phenotype of gliomasCANCER RESEARCH
Artículo2010Regulation of the MicroRNA Processor DGCR8 by the Tumor Suppressor ING1CANCER RESEARCH
Revisión2009Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?CANCER RESEARCH
Artículo2008A pivotal role for heat shock protein 90 in Ewing Sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: in vitro and in vivo studyCANCER RESEARCH
Artículo2006Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cellsCANCER RESEARCH